Back to search

Article

Clinical investigation of VES001, a novel oral small molecule sortilin receptor inhibitor, for the treatment of frontotemporal dementia

2026-03-31

Abstract excerpt

<title>Abstract</title> <p>GRN gene haploinsufficiency reduces progranulin and causes frontotemporal dementia (FTD-GRN). Restoring progranulin to physiological levels counteracts the molecular deficit underlying the disease. VES001 is an orally administered small molecule sortilin inhibitor that increases progranulin by blocking its interaction with sortilin without downregulating sortilin. In preclinical studies...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
ae93ab63-62e7-5efa-88a4-0d899cf2a098
DOI
10.21203/rs.3.rs-8405910/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Clinical investigation of VES001, a novel oral small molecule sortilin receptor inhibitor, for the treatment of frontotemporal dementiaDOI 10.21203/rs.3.rs-8405910/v1
Select a neighboring publication to make it the new centre.